Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
1,577,408
-
Share change
-
+5,922
-
Total reported value
-
$18,609,960
-
Price per share
-
$11.80
-
Number of holders
-
28
-
Value change
-
+$657,198
-
Number of buys
-
10
-
Number of sells
-
12
Institutional Holders of Passage BIO, Inc. - COM NEW (PASG) as of Q4 2025
As of 31 Dec 2025,
Passage BIO, Inc. - COM NEW (PASG) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,577,408 shares.
The largest 10 holders included
Lynx1 Capital Management LP, Vestal Point Capital, LP, VANGUARD GROUP INC, Eversept Partners, LP, RENAISSANCE TECHNOLOGIES LLC, Erste Asset Management GmbH, Yiheng Capital Management, L.P., GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., and ACADIAN ASSET MANAGEMENT LLC.
This page lists
28
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.